CHEK2 and breast cancer: It can be assumed that breast cancer risk associated with pathogenic CHEK2 variants in the general population would be at the lower moderate penetrance gene border (OR > 2) but considerably higher (though still in a moderate penetrance range; with OR < 4) for high-risk carriers from families with a positive cancer history.